Imunon Inc (IMNN)
0.9799
+0.03
(+3.15%)
USD |
NASDAQ |
Nov 04, 16:00
0.98
0.00 (0.00%)
After-Hours: 04:23
Imunon Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.2058 |
| September 30, 2022 | 0.1449 |
| June 30, 2022 | 0.1264 |
| March 31, 2022 | 0.1275 |
| December 31, 2021 | 0.1049 |
| September 30, 2021 | 0.0979 |
| June 30, 2021 | 0.09 |
| March 31, 2021 | 0.0926 |
| December 31, 2020 | 0.2714 |
| September 30, 2020 | 0.2703 |
| June 30, 2020 | 0.4129 |
| March 31, 2020 | 0.6108 |
| December 31, 2019 | 0.6734 |
| September 30, 2019 | 0.6278 |
| June 30, 2019 | 0.5102 |
| March 31, 2019 | 0.4447 |
| December 31, 2018 | 0.4514 |
| September 30, 2018 | 0.6159 |
| June 30, 2018 | 0.4816 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.241 |
| December 31, 2016 | 0.3807 |
| Date | Value |
|---|---|
| September 30, 2016 | 0.3399 |
| June 30, 2016 | 0.2773 |
| March 31, 2016 | 0.3606 |
| December 31, 2015 | 0.3151 |
| September 30, 2015 | 0.2919 |
| June 30, 2015 | 0.2801 |
| March 31, 2015 | 0.3349 |
| December 31, 2014 | 0.2957 |
| September 30, 2014 | 0.2464 |
| June 30, 2014 | 0.2126 |
| March 31, 2014 | 0.1233 |
| December 31, 2013 | 0.159 |
| September 30, 2013 | 0.1473 |
| June 30, 2013 | 0.1441 |
| March 31, 2013 | 0.1566 |
| December 31, 2012 | 0.424 |
| September 30, 2012 | 0.3905 |
| June 30, 2012 | 0.3498 |
| March 31, 2012 | 0.0067 |
| December 31, 2011 | 0.0069 |
| September 30, 2011 | 0.0049 |
| June 30, 2011 | 0.2455 |
| March 31, 2011 | -0.0299 |
| December 31, 2010 | -0.0393 |
| September 30, 2010 | -0.2472 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.09
Minimum
Jun 2021
0.6734
Maximum
Dec 2019
0.2484
Average
0.1449
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Merck & Co Inc | 0.8671 |
| Cormedix Inc | 0.00 |
| Brainstorm Cell Therapeutics Inc | -- |
| Predictive Oncology Inc | 0.0676 |
| Outlook Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.692M |
| Total Liabilities (Quarterly) | 5.950M |
| Shareholders Equity (Quarterly) | 3.741M |